Orphan disease specialists find home with Big Pharma..
By Maura Musciacco, Senior Analyst
25 January 2013
The article offers an introduction to the ongoing trends within the orphan drug market, focusing on the leading pharmaceutical players in this field. A growing number of companies have turned to deal-making activity with specialist firms in an effort to secure promising pipeline candidates. Datamonitor has identified 8 potential takeover targets for Big Pharma, which could enable rapid sales growth in the orphan drug market.
To download your free white paper please fill out the adjacent form